JOHN KING: Open Payments
NPI 1538947957 · WENATCHEE, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,810 in 136 payments from 15 companies in 2025. Trend: 2023 $343 · 2024 $3,972 · 2025 $2,810
Food & beverage: $2,726Education: $84
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 40 | $818 |
| Janssen Biotech, Inc. | 20 | $377 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 24 | $374 |
| Aimmune Therapeutics, Inc. | 7 | $170 |
| PFIZER INC. | 8 | $167 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $162 |
| Boston Scientific Corporation | 1 | $160 |
| Phathom Pharmaceuticals, Inc. | 7 | $148 |
| Madrigal Pharmaceuticals | 4 | $109 |
| Regeneron Healthcare Solutions, Inc. | 5 | $103 |
Products named: TREMFYA, XIFAXAN, RINVOQ, SKYRIZI, ZENPEP, ENTYVIO, WaveWriter Alpha Prime 16, VOQUEZNA.
Industry payments across WA — which companies pay providers there.
